4D Molecular Therapeutics Cash from Operations (TTM) Analysis

4D Molecular Therapeutics Inc (FDMT)

26.37 +0.98 (+3.86%) USD | NASDAQ | May 02, 16:00

26.40 +0.04 (+0.13%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-75.79M
September 30, 2023	-73.36M
June 30, 2023	-93.20M
March 31, 2023	-91.04M
December 31, 2022	-86.68M
September 30, 2022	-86.31M
June 30, 2022	-81.01M

Date	Value
March 31, 2022	-77.31M
December 31, 2021	-69.13M
September 30, 2021	-64.80M
June 30, 2021	-62.45M
March 31, 2021	-52.41M
December 31, 2020	-50.91M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-93.20M

Minimum

Jun 2023

-50.91M

Maximum

Dec 2020

-74.18M

Average

-75.79M

Median

Dec 2023

Cash from Operations (TTM) Benchmarks